NCT06650527 · RECRUITING

Effect of Cognitive Empathy Training on Dementia Caregivers

This trial is testing whether a behavioral training program called cognitive empathy training can improve mental health, reduce inflammation, and support immune function in people who care for someone with dementia. It is a Phase NA trial, meaning it is a behavioral intervention study rather than a drug trial. Researchers will use blood samples and MRI scans to look at physical changes alongside mental health outcomes. Details on session format and length are limited.

You may qualify if

  • Caregivers must live with their care recipient
  • Caregivers must have a Zarit Burden Scale score of 19 or higher
  • Caregivers must have no plans to move their care recipient to an institutional setting within the next year
  • Caregivers must be able to read and write English
  • Care recipient not in hospice
  • Access to a mobile phone that can take and email photographs

You're excluded if

  • Subjects with a history of seizures or other neurological disorders, alcoholism, or any other substance abuse
  • Subjects with a history of psychiatric illness (excluding depression and anxiety disorders) will also be excluded
  • Subjects with a history of head trauma based on Survey
  • Subjects with MRI contra-indications

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials